1. Home
  2. Inhibitor
  3. E2030

E2030

General

Type : Pyridine,Boron compound

Chemical_Nomenclature : [2-methoxy-5-[(E)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethenyl]pyridin-4-yl]methanamine

Canonical SMILES : B1(OC(C(O1)(C)C)(C)C)C=CC2=CN=C(C=C2CN)OC

InChI : InChI=1S\/C15H23BN2O3\/c1-14(2)15(3,4)21-16(20-14)7-6-11-10-18-13(19-5)8-12(11)9-17\/h6-8,10H,9,17H2,1-5H3\/b7-6+

InChIKey : LAGBVTUFYIBFIX-VOTSOKGWSA-N

Other name(s) : E-2030,3-(2-(1-(1,3-dioxolan-2-ylmethyl)-4-piperidyl)ethyl)-2H-3,4-dihydro-1,3-benzoxazin-2,4-dione hydrochloride

MW : 290.16

Formula : C15H23BN2O3

CAS_number :

PubChem : 74890773

UniChem : LAGBVTUFYIBFIX-VOTSOKGWSA-N

IUPHAR :

Wikipedia :

Target

Families : E2030 ligand of proteins in family: ACHE || BCHE

Stucture :

Protein :

References (1)

Title : Central and peripheral activity of cholinesterase inhibitors as revealed by yawning and fasciculation in rats - Ogura_2001_Eur.J.Pharmacol_415_157
Author(s) : Ogura H , Kosasa T , Kuriya Y , Yamanishi Y
Ref : European Journal of Pharmacology , 415 :157 , 2001
Abstract : Ogura_2001_Eur.J.Pharmacol_415_157
ESTHER : Ogura_2001_Eur.J.Pharmacol_415_157
PubMedSearch : Ogura_2001_Eur.J.Pharmacol_415_157
PubMedID: 11274994